Abstract:OBJECTIVE: Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease, whereas its cause still remains elusive. Typical pathological manifestations of RA include persistent synovitis and bone degeneration in the surrounding joints. Although the incidence of RA is high in population, currently there have been no effective cures for it. The purpose of this study is to investigate the therapeutic effects and main mechanism of IKK epsilon (inhibitor of nuclear factor kappa-B kinase epsilon) in collagen II induced-Rheumatoid Arthritis (CIA) mice model. MATERIALS AND METHODS: IKK epsilon(-/-) and wild-type (WT) littermate control mice were intraperitoneally injected with 5 mg/kg collagen II monoclonal antibody cocktail (Cab) for 5 days. After that, the nociception threshold and clinical rheumatoid arthritis articular damage score of mice were evaluated. After 5 days-CAb treatment, serum levels of a series of inflammatory cytokines including interleukin-6 (IL-6), IL1 beta, tumor necrosis factor-alpha (TNF-alpha) and interferon (IFN) were detected with enzyme-linked immunosorbent assay (ELISA) in both groups. Besides, Real-time reverse transcription polymerase chain reaction (Real-time RT-PCR) was used to evaluate the expression of these inflammatory cytokines in plantar tissues. In addition, Western blot was performed to investigate the protein levels of NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B) signaling pathway. Moreover, WT mice receiving CAb were further applied with or without IKK epsilon inhibitor amlexanox (25 mg/kg) to investigate the expression of the above-mentioned inflammatory cytokines. RESULTS: Our work showed that IKK epsilon(-/-) mice with CIA displayed less nociception and suppressed inflammatory response than WT mice. Meanwhile, the clinical rheumatoid arthritis articular damage scores were significantly decreased in IKK epsilon(-/-) mice. The levels of TNF-alpha, IL-1 beta, IL-6 in serum and plantar tissues in IKK epsilon(-/-) mice were significantly lower than those in WT mice. Besides, NF-kappa B expression in IKK epsilon(-/-) mice was significantly decreased. Similarly, the same phenotype was observed in WT mice administrated with IKKe inhibitor amlexanox as that of IKK epsilon(-/-) mice, indicating that inflammatory and nociception responses were remarkably decreased than those of the negative controls. CONCLUSIONS: IKK epsilon plays an important role in promoting nociception and inflammatory response in CIA. Our research demonstrated that knockout of IKK epsilon may serve as a new direction for clinical prevention and treatment of rheumatoid arthritis. IKK epsilon inhibitor amlexanox may become a new drug for the treatment of rheumatoid arthritis.

IK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activation

Targeting Kinase ITK Treats Autoimmune Arthritis Via Orchestrating T Cell Differentiation and Function

Rkip Mediates Autoimmune Inflammation By Positively Regulating Il-17r Signaling

IKKε Aggravates Inflammatory Response Via Activation of NF-κB in Rheumatoid Arthritis.

Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Invariant Natural Killer T Cells Regulate Conventional Dendritic Cell Maturation to Re-establish Immune Tolerance to Rheumatoid Arthritis in DBA/1 Mice

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice

Inhibition of the IL-18 Receptor Signaling Pathway Ameliorates Disease in a Murine Model of Rheumatoid Arthritis

Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression

SIRT1 inhibits differentiation of monocytes to macrophages: amelioration of synovial inflammation in rheumatoid arthritis

Inhibition of Histone H3 Lysine-27 Demethylase Activity Relieves Rheumatoid Arthritis Symptoms Via Repression of IL6 Transcription in Macrophages

Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics.

Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1

Jnk1 Controls Mast Cell Degranulation and Il-1 Beta Production in Inflammatory Arthritis

Exosome-mediated delivery of super-repressor IκBα alleviates inflammation and joint damages in rheumatoid arthritis

Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis

IĸBζ is a central modulator of inflammatory arthritis pathogenesis

Macrophage re-programming by JAK inhibitors relies on MAFB

Inhibition of Notch1 induces population and suppressive activity of regulatory T cell in inflammatory arthritis